Integrating adverse outcome pathways (AOPs) and high throughput in vitro assays for better risk evaluations, a study with drug-induced liver injury (DILI)
doi:10.1113/jphysiol.2009.178053 Zozina VI, Covantev S, Goroshko OA, Krasnykh LM, Kukes VG
This refractory fraction of CAD, especially given its procedure-resistant microvascular nature, requires urgent development of pharmacological adjuncts to the current armamentarium
Managing side effects is key to sticking with treatment
For liposomal glutathione, you usually do not require that much 100 mg to 300 mg to 300 mg is common because your body better absorbs it
Yan X, Liao H, Cheng M, Shi X, Lin X, Feng XH, Chen YG